✦ LIBER ✦

Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children

✍ Scribed by B. Winograd; R. J. J. Lippens; M. J. M. Oosterbaan; M. J. M. Dirks; T. B. Vree; E. Kleijn

Publisher: Springer
Year: 1986
Tongue: English
Weight: 782 KB
Volume: 30
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00614310

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of methotrexate and 7-h

Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receivinglow-dose oral methotrexate

✍ P. Sonneveld; F. W. Schultz; K. Nooter; K. Hählen 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 523 KB

Pharmacokinetic modeling of plasma and c

Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children

✍ E. Chatelut; H. Roche; Y. Plusquellec; F. Peyrille; J. De Biasi; A. Pujol; P. Ca 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

A pharmacokinetic study was performed in plasma and cerebrospinal fluid (CSF) of patients suffering from brain tumors to describe the disposition of methotrexate. An open three-compartment model was developed to fit together the data obtained in plasma and CSF. The pharmacokinetic parameters obtaine

Effect of methotrexate on the pharmacoki

Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatin

✍ R. Preiss; V. K. Brovtsyn; N. I. Perevodchikova; M. B. Bychkov; H. Hüller; L. A. 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 760 KB

Degradation and clearance of methotrexat

Degradation and clearance of methotrexate in children with osteosarcoma receiving high-dose infusion

✍ Wang, Yeu-Ming ;Kim, Pyong-Young ;Lantin, Erlinda ;van Eys, D. Catherine ;Romsda 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

## Abstract Plasma methotrexate (MTX) concentrations were quantitated in 34 patients after 127 high‐dose (35–350 mg/kg) infusions with citrovorum factor rescue. Significant linear correlations have been obtained between methotrexate dosage and concentrations in plasma at 6 and 24 hours after the in

Renal impairment following the combined

Renal impairment following the combined use of high-dose methotrexate and procarbazine

✍ P. Price; H. Thompson; E. M. Bessell; H. J. G. Bloom 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 233 KB

A major side-effect of high-dose methotrexate is renal toxicity, which may develop unexpectedly despite adequate standard precautions such as hydration and alkalinisation of the urine. The pathogenesis is unclear. Recent reports suggest that the combination of high-dose methotrexate with non-chemoth

Pharmacokinetic study of methotrexate, f

Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue

✍ C. Wolfrom; R. Hepp; R. Hartmann; H. Breithaupt; G. Henze 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 850 KB

The pharmacokinetics of methotrexate (MTX), 7-hydroxymethotrexate (7-OHMTX), 2,4-diaminomethylpteroic acid (APA), folinic acid, and 5-methyltetrahydrofolate (5-MTHF) have been studied during 21 high-dose MTX (HDMTX) infusions (5 g.m-2 in 24 h) with leucovorin (LCV) rescue, a component of the therapy